NHP Based Ophthalmic Gene Therapy Platform

Creative Biolabs: Expert in NHP-based ophthalmic gene therapy solutions!

As a global leader in the gene therapy industry, Creative Biolabs is devoted to promoting the study of various ocular diseases with high incidence worldwide. To date, we have cooperated with many research groups to advance the clinical translation of promising therapeutics. Our extensive experience and expertise in the ophthalmic gene therapy field enable us to support your research with the most suitable solution.

Applications of Gene Therapy in Ocular Disease Studies

Due to the treatment complexity of ophthalmic diseases, an enormous number of patients around the world are currently suffering from this health problem. Gene therapy, as an emerging therapeutic development tool, is increasingly playing an essential role in research on refractory eye diseases, especially for inherited retinal diseases, age-related macular degeneration (AMD), as well as glaucoma. This versatile technology allows researchers to reconstruct animal phenotypes through gene editing technology and bring therapy to the eye by a viral or non-viral vector, eventually achieving the purpose of treatment or cure. With the continuous deepening of research, gene therapy has expanded its scope of application in ophthalmology, making gene therapy for more eye diseases possible.

Our NHP-based Ophthalmic Gene Therapy Platform

At Creative Biolabs, our NHP-based ophthalmic gene therapy platform utilizes cutting-edge genome editing strategies, AAV vectors of multiple serotypes, and a variety of ocular injection methods to help our clients carry out the ophthalmic gene therapy development. We have established a highly qualified research team with a multidisciplinary background and can provide professional technical support and feasible practical advice. Particularly, our NHP-based ophthalmic gene therapy platform can undertake various preclinical NHP-based research programs, such as pharmacology and pharmacodynamics, pharmacokinetics, safety assessment, as well as biomarker discovery and validation research. Besides, we also offer customization services to meet your specific requirements.

Why Partner with Us

At Creative Biolabs, we understand that development in the biological field is never-ending and thus our team always keeps track of the latest research results and various emerging technologies. Continuous development and progress keep us ahead of the industry. In the future, we will also continue to launch more high-quality products and assured services to give back to our customers. If you are conducting an ophthalmic gene therapy project, don't hesitate to contact us for more detailed information.

Fig.1 The strengths of Creative Biolabs in NHP-based ophthalmic gene therapy platform (Creative Biolabs Original)

Online Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

NHP Biologicals from Creative Biolabs are for research, diagnostic, or manufacturing purposes only. They may not be intended for or are not approved for any other use.

USA
Tel:
Fax:
Email:
UK (for antibody and medium reagents only)
Tel:
Email:
Germany
Tel:
Email:

Enter your email here to subscribe.

Submit

Follow us on

Copyright © 2024 Creative Biolabs. All rights reserved.
Cart
  • 0
  • 0
Cart